Literature DB >> 22660276

The role of epigenetic regulation in stem cell and cancer biology.

Lilian E van Vlerken1, Elaine M Hurt, Robert E Hollingsworth.   

Abstract

Normal development and homeostasis requires a carefully coordinated gene expression program. Appropriate transcriptional regulation is maintained, in part, through epigenetic modifications of both DNA and histones. It is now apparent that the epigenetic landscape is complex and carefully controlled to both silence and activate gene transcription and that these states remain exquisitely poised for reversal. The deregulation of epigenetics in cancer is common and results in both the activation of oncogenes and the silencing of tumor suppressors. A tremendous amount of research corroborates the existence in many tumor types of a cancer stem cell that is both the origin and cell type responsible for resistance of tumors to current therapies. As our understanding of cancer stem cell biology continues, it is apparent that these cells are also under the influence of epigenetic regulation. We will discuss the cancer stem cell hypothesis and the role of epigenetics in both normal and cancer stem cell biology.

Entities:  

Mesh:

Year:  2012        PMID: 22660276     DOI: 10.1007/s00109-012-0917-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  138 in total

Review 1.  Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.

Authors:  Stuart Atkinson; Lyle Armstrong
Journal:  Cell Tissue Res       Date:  2007-11-15       Impact factor: 5.249

2.  Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage.

Authors:  Wen-Hui Lien; Xingyi Guo; Lisa Polak; Lee N Lawton; Richard A Young; Deyou Zheng; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2011-09-02       Impact factor: 24.633

Review 3.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

4.  H3K36 methylation antagonizes PRC2-mediated H3K27 methylation.

Authors:  Wen Yuan; Mo Xu; Chang Huang; Nan Liu; She Chen; Bing Zhu
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

5.  Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.

Authors:  Siân Rizzo; Jenny M Hersey; Paul Mellor; Wei Dai; Alessandra Santos-Silva; Daniel Liber; Louisa Luk; Ian Titley; Craig P Carden; Garry Box; David L Hudson; Stanley B Kaye; Robert Brown
Journal:  Mol Cancer Ther       Date:  2011-01-07       Impact factor: 6.261

6.  Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins.

Authors:  David J Seward; Gabrielle Cubberley; Soojin Kim; Matt Schonewald; Lian Zhang; Brian Tripet; David L Bentley
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

Review 7.  Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.

Authors:  Frank Pajonk; Erina Vlashi; William H McBride
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

8.  Promoter hypomethylation regulates CD133 expression in human gliomas.

Authors:  Kouichi Tabu; Ken Sasai; Taichi Kimura; Lei Wang; Eiko Aoyanagi; Shinji Kohsaka; Mishie Tanino; Hiroshi Nishihara; Shinya Tanaka
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

9.  EZH2 is essential for glioblastoma cancer stem cell maintenance.

Authors:  Mario-Luca Suvà; Nicolò Riggi; Michalina Janiszewska; Ivan Radovanovic; Paolo Provero; Jean-Christophe Stehle; Karine Baumer; Marie-Aude Le Bitoux; Denis Marino; Luisa Cironi; Victor E Marquez; Virginie Clément; Ivan Stamenkovic
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

10.  Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Authors:  Elaine Lai-Han Leung; Ronald R Fiscus; James W Tung; Vicky Pui-Chi Tin; Lik Cheung Cheng; Alan Dart-Loon Sihoe; Louis M Fink; Yupo Ma; Maria Pik Wong
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more
  10 in total

1.  Stem cell biology--from basic research to regenerative medicine.

Authors:  Daniel Besser
Journal:  J Mol Med (Berl)       Date:  2012-07       Impact factor: 4.599

Review 2.  Role of epigenetic modifications in luminal breast cancer.

Authors:  Hany A Abdel-Hafiz; Kathryn B Horwitz
Journal:  Epigenomics       Date:  2015-02-17       Impact factor: 4.778

Review 3.  AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

Authors:  Bowen Yan; David Claxton; Suming Huang; Yi Qiu
Journal:  Exp Hematol       Date:  2020-06-20       Impact factor: 3.084

Review 4.  Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.

Authors:  Aamir Ahmad; Yiwei Li; Bin Bao; Dejuan Kong; Fazlul H Sarkar
Journal:  Mol Nutr Food Res       Date:  2013-11-24       Impact factor: 5.914

5.  Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations.

Authors:  Sagi Abelson; Yeela Shamai; Liron Berger; Karl Skorecki; Maty Tzukerman
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

6.  Prognostic value of cross-omics screening for kidney clear cell renal cancer survival.

Authors:  Slavica Dimitrieva; Ralph Schlapbach; Hubert Rehrauer
Journal:  Biol Direct       Date:  2016-12-20       Impact factor: 4.540

Review 7.  Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.

Authors:  Hany A Abdel-Hafiz
Journal:  Diseases       Date:  2017-07-06

Review 8.  Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.

Authors:  Srikanta Dash; Yucel Aydin; Kyle E Widmer; Leela Nayak
Journal:  J Hepatocell Carcinoma       Date:  2020-04-15

9.  Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells.

Authors:  Xavier Tekpli; Alfonso Urbanucci; Adnan Hashim; Cathrine B Vågbø; Robert Lyle; Marianne K Kringen; Anne Cathrine Staff; Ingunn Dybedal; Ian G Mills; Arne Klungland; Judith Staerk
Journal:  Epigenetics Chromatin       Date:  2016-05-31       Impact factor: 4.954

Review 10.  New Findings on Breast Cancer Stem Cells: A Review.

Authors:  Azam Bozorgi; Mozafar Khazaei; Mohammad Rasool Khazaei
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.